29 biotech investors in New York, including 24 in New York City
We list 29 biotech investors in New York as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (23), Tuxedo Park (1) and Hicksville (1). 24 of the 29 are in the New York City metro area, so this page is also our list of biotech investors in New York City.
Top 5 biotech investors in New York, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Digitalis Ventures
Type: VC firm · HQ: New York, NY · Stages: Seed · Focus: Biotech, Healthtech, Medtech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $862M (SEC Form ADV)
Portfolio news dated Nov 2026; $862M on file (SEC Form ADV); states biotech and life sciences as a focus; names the US as where it invests; 8 named decision-makers on file.
HOF Capital
Type: VC firm · HQ: New York, NY · Stages: Any stage · Focus: Biotech, AI, Fintech, Consumer · Latest activity: New fund, Aug 2026 · Fund size on file: $300M (SEC Form D, 2021)
Latest fund filing dated Aug 2026; $300M fund on file (SEC Form D, 2021); 11% of its observed portfolio is biotech and life sciences; names the US as where it invests; 2 named decision-makers on file.
Union Square Ventures
Type: VC firm · HQ: New York, NY · Stages: Seed, Series A · Focus: Biotech, AI, Generalist, Robotics · Latest activity: New deal, Oct 2026 · Fund size on file: $3M (SEC Form D, 2026)
Dated new deal in Oct 2026; $3M fund on file (SEC Form D, 2026); states biotech and life sciences as a focus; names the US as where it invests; 8 named decision-makers on file.
Jeito
Type: VC firm · HQ: New York, NY · Focus: Biotech, Healthtech · Latest activity: New deal, Jun 2026
Dated new deal in Jun 2026; 100% of its observed portfolio is biotech and life sciences; names the US as where it invests; 8 named decision-makers on file.
Aisling Capital
Type: VC firm · HQ: New York, NY · Stages: Seed · Focus: Biotech, Healthtech, Food and Beverage, Medtech · Latest activity: Portfolio news, Jul 2026 · Private fund assets: $64M (SEC Form ADV)
Portfolio news dated Jul 2026; $64M on file (SEC Form ADV); 92% of its observed portfolio is biotech and life sciences; 8 named decision-makers on file.
First 14 of 29 biotech investors in New York
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Digitalis Ventures | VC firm | New York, NY | Seed | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| HOF Capital | VC firm | New York, NY | Any stage | Biotech, AI, Fintech, Consumer | New fund, Aug 2026 | $300M (SEC Form D, 2021) | 4 Nov 2026 | 2 names · Unlock |
| Union Square Ventures | VC firm | New York, NY | Seed, Series A | Biotech, AI, Generalist, Robotics | New deal, Oct 2026 | $3M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| Jeito | VC firm | New York, NY | Biotech, Healthtech | New deal, Jun 2026 | 5 Nov 2026 | 8 names · Unlock | ||
| Aisling Capital | VC firm | New York, NY | Seed | Biotech, Healthtech, Food and Beverage, Medtech | Portfolio news, Jul 2026 | $64M (SEC Form ADV) | 5 Nov 2026 | 8 names · Unlock |
| Ghic | VC firm | New York, NY | Biotech, Healthtech, Impact, Medtech | New fund, May 2026 | $270M (SEC Form ADV) | 5 Nov 2026 | No contact on file | |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Biotech, Healthtech, Medtech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Eckuity Capital | VC firm | New York, NY | Growth | Biotech, Healthtech, Medtech | New fund, Jun 2026 | $300M (SEC Form D, 2026) | 4 Nov 2026 | 1 name · Unlock |
| Apple Tree Venture | VC firm | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Biotech, Healthtech | Portfolio news, Sep 2025 | $3.5B (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Antler | Accelerator | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Biotech, AI, Healthtech, Consumer | New deal, Aug 2026 | $90M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| MBX Capital | VC firm | Tuxedo Park, NY | Seed | Biotech, Healthtech, Medtech | New deal, Jul 2026 | $50M (SEC Form D, 2023) | 5 Nov 2026 | 2 names, firm email · Unlock |
| Overlap Holdings | VC firm | Hicksville, NY | Seed, Series A, Series B | Biotech, AI, Energy, Climate Tech | New fund, Oct 2026 | $16M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| Black Opal Ventures | VC firm | New York, NY | Biotech, Healthtech, SaaS, Medtech | New fund, Aug 2026 | $75M (SEC Form D, 2026) | 4 Nov 2026 | 7 names · Unlock | |
| Cerberus Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A, Series B | Biotech, AI, Industrial Tech, Quantum | New fund, Jun 2026 | $75M (SEC Form D, 2024) | 4 Nov 2026 | 8 names · Unlock |
You are seeing 14 of 29. The full list adds 15 more investors and 157 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
24 biotech investors in New York City
19 of the 24 have a fund filing or a dated deal in the last 12 months; the median fund size on file is $75M (SEC Form D, 14 firms); the most recent fund filings are from Arcventis Health Partners (Sep 2026), HOF Capital (Aug 2026) and Union Square Ventures (Aug 2026); of the 16 with a stage on file, seed (10), growth-stage (7) and Series A (6); the count covers the metro area, by city: New York (23) and Brooklyn (1); the paid file holds 129 named decision-makers for them.
The first 5 in list order: Digitalis Ventures, HOF Capital, Union Square Ventures, Jeito and Aisling Capital. They are ranked with the rest of the list, by the same rule.
How these 29 break down
By city
| City | On this list | Share |
|---|---|---|
| New York | 23 | 79% |
| Tuxedo Park | 1 | 3% |
| Hicksville | 1 | 3% |
| White Plains | 1 | 3% |
| Garden City | 1 | 3% |
| Brooklyn | 1 | 3% |
| Nissequogue | 1 | 3% |
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 6 | 21% |
| Seed | 14 | 48% |
| Series A | 8 | 28% |
| Series B | 7 | 24% |
| Growth | 7 | 24% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 28 | 97% |
| Accelerator | 1 | 3% |
Method and limits
- Source
- All 29 rows carry an SEC filing (Form D or Form ADV). All 29 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in New York.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 6 Nov 2026.
- Fill rates
- Of 29 rows: stage 21, sector 29, fund size 24, website 29. In the paid file: named decision-makers on 28 rows, firm email on 8, LinkedIn page on 10, check size on 0.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many biotech investors in New York are there?
We list 29 as of November 2026. 22 of the 29 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (23), Tuxedo Park (1) and Hicksville (1).
Which biotech investors in New York raised a new fund in the last 12 months?
12 of the 29 have a fund filing dated in the last 12 months. The most recent on this list are Overlap Holdings (Oct 2026), Arcventis Health Partners (Sep 2026) and HOF Capital (Aug 2026).
What is the typical fund size of biotech investors in New York?
The median fund size on file for this list is $66M, across the 16 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 13 do not disclose a size there.
How do I contact biotech investors in New York?
The paid file holds 157 named decision-makers across 28 of these 29 and a firm email for 8. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on biotech investors in New York come from?
All 29 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.
Related lists
AI investors in New York (159)SaaS investors in New York (138)Biotech investors in California (108)Healthtech investors in New York (100)Fintech investors in New York (98)Consumer investors in New York (59)Medtech investors in New York (53)Energy investors in New York (43)Deep tech investors in New York (42)Climate tech investors in New York (40)Biotech investors in Massachusetts (37)B2B investors in New York (34)Industrial tech investors in New York (34)Cybersecurity investors in New York (33)Developer tools investors in New York (31)Hardware investors in New York (30)Crypto and web3 investors in New York (30)Logistics investors in New York (24)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to biotech and life sciences and New York. Guide: new venture funds and capital raised by state. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.